−£226k
vs Feb 2024Active03914021Private limited companyLondon
IMMUNOCLIN LIMITED
Significant control: Dr Dorothy H Bray (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Immunoclin Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Immunoclin Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
IMMUNOCLIN LIMITED is an active private limited company (company number 03914021) incorporated on 26 January 2000, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest micro accounts cover the period ending 28 February 2025, showing net assets of −£226k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 8% on the prior period (−£210k).
Peer position · net assets
By net assets it sits in the bottom quarter of 76 comparable companies in London (median £100, upper quartile £88k).
02
Ownership and control
- Dr Dorothy H Bray
- owns 75–100% of shares
- Maitland Pharma Corp
- owns 75–100% of shares
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 January 200026 yrs ago
- Next accounts due
- 28 November 2026in 35 days
- Confirmation statement due
- 9 February 2027in 108 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 71200
- Technical testing and analysis
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
Not reported the period before| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | −£226k | — | — | £287k | — | — | 2 |
| 29 February 2024 | −£210k | — | — | £346k | — | — | — |
Current ratio0.07Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-226,364 at 28 February 2025
- Current assets below creditors within one yearCurrent ratio 0.07
- Incorporated five or more years agoIncorporated 26 January 2000
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 108 days
- Next accounts duein 35 days
- Accounts period endNet liabilities £226k · micro accounts
- Accounts period endNet liabilities £210k · micro accounts
- Incorporated
08
Similar companies in London
- Y4U LIMITEDinc. Oct 1999
- THE ORGANIC PHARMACY LIMITEDLondon · inc. Jun 2000
- AMBE LIMITEDNew Eltham · inc. Jul 1999
- NEW FUTURE NOW LIMITEDLondon · inc. Dec 2001
- SALCURA LIMITEDLondon · inc. Apr 2002
- FOCUS PHARMACEUTICALS LIMITEDLondon · inc. Aug 2002
All companies incorporated on 26 January 2000 · in Jan 2000.
09
Reminders for IMMUNOCLIN LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.